Officially

From the publisher, with its history intact.

Life Sciences Organisation gov.uk

Guidance: Genomics and personalised medicines: partner with the UK to develop new treatments

Imported from official source

Safety Classified by Officially

The UK is one of the best locations in the world to develop and commercialise genomics technologies and personalised medicines.

The UK’s track record of discovery in genomics is world renowned, and includes:

  • the innovation of the Solexa sequencing platform (now Illumina’s core technology)
  • its leadership in setting up and leading the 100,000 genomes project

    • The UK is at the forefront of genomics research. It is the first nation in the world to:

  • apply whole genome sequencing at scale in direct healthcare
  • provide access to high quality de-identified clinically linked genomic data for research

    • Genomics England was created to make the UK the first country to introduce genomics technology into its mainstream health system. It has led the global race for better tests, better drugs and more personalised care, and already reached its target of sequencing 100,000 genomes.

    Over the next 5 years, Genomics England will continue to play a crucial role in the UK’s plan to sequence 5 million genomes, including at least 1 million whole genomes from the National Health Service (NHS) and UK Biobank.

    Advantages of the UK as a partner to develop genomics technologies

  • leading-edge research and talent, available at centres of excellence such as the Wellcome Trust Sanger Institute and Wellcome Genome Campus
  • established infrastructure for innovation and clinical trials
  • support for technology development and informatics platforms
  • world-renowned regulatory expertise and standards
  • specialised infrastructure to support the introduction of genomic medicine into the NHS

    • Examples of specific genomics commitments include:

  • an £85 million investment in whole genome sequencing of UK Biobank
  • the extension of the cancer genome pathway from the 100,000 genomes project
  • delivering the results of the 100,000 genomes project to patients by the end of 2019

    • This is an extract. The publication continues at the source.

    Read the original at the source: https://www.gov.uk/government/publications/genomics-and-personalised-medicines-partner-with-the-uk-to-develop-new-treatments

    Officially imported this from Life Sciences Organisation’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

    Provenance

    Organization
    Life Sciences Organisation — imported from official source
    Official source
    https://www.gov.uk/government/organisations/life-sciences-organisation.atom ATOM
    Imported
    September 20, 2026 19:53
    Versions
    1 recorded
    Identity
    https://www.gov.uk/government/publications/genomics-and-personalised-medicines-partner-...

    Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.